Antiviral drugs targeting RNAs.
A research program to develop low molecular weight antiviral drugs targeting functional structured RNA elements in the genome of coronaviruses and beyond.
In response to the current pandemic elicited by In RNA-drugs we want to establish a platform to develop small molecules as drugs against viral RNA targets by a structure-guided drug development approach.